Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer
Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer is a paper indexed in PICO Portal from OpenAlex.
How many citations does Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer have?
Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer has 76 citations in the OpenAlex counts PICO Portal stores.
When was Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer published?
Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer has 2022 year in the PICO Portal index.
What is the open-access status of Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer?
Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer has closed oa status in the PICO Portal index.
What is the DOI of Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer?
The DOI for Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer is on the source record.
What is the PMID of Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer?
The PMID for Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer is on the source record.
What is the OpenAlex record for Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer?
The OpenAlex for Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer is on the source record.